Skip to main content
Log in

Expression of Arginine Deiminase from Pseudomonas plecoglossicida CGMCC2039 in Escherichia coli and Its Anti-Tumor Activity

  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

Arginine deiminase (ADI), an arginine-degrading enzyme, has been studied as a potential anti-cancer agent in clinical trials for the treatment of arginine-auxotrophic tumors, such as hepatocellular carcinomas (HCCs) and melanomas. The arcA gene encoding ADI was cloned from a recently isolated strain Pseudomonas plecoglossicida CGMCC2039. The nucleotide sequence of ADI comprises an ORF of 1,254 bp encoding 417 amino acids. The deduced ADI protein sequence has a calculated molecular weight of 46.5 kDa and shows 97% and 85% identity to ADIs from P. putida and P. aeruginosa, respectively. The arcA from P. plecoglossicida CGMCC2039 was expressed in Escherichia coli BL21 with a N-terminal His6-tag, and purified to homogeneity. A molecular mass of approximate 49 kDa was confirmed by SDS-PAGE analysis and specific activity was determined to be 4.76 U/mg (pH 6.0 and 37°C). In vivo activity study showed that the rADI could effectively inhibit H22 tumor growth at a total dose of 5 U/mouse over a 2-week dosing period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Boyde TRC, Rahmatullah M (1980) Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal Biochem 107:424–431

    Article  PubMed  CAS  Google Scholar 

  2. Burne RA, Parsons DT, Marquis RE (1989) Cloning and expression in Escherichia coli of the genes of the arginine deiminase system of Streptococcus sanguis NCTC 10904. Infect Immun 57:3540–3548

    PubMed  CAS  Google Scholar 

  3. Das K, Butler GH, Kwiatkowski V et al (2004) Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism. Structure 12:657–667

    Article  PubMed  CAS  Google Scholar 

  4. Ensor CM, Holtsberg FW, Bomalaski JS et al (2002) Pegylated arginine deiminase (ADI-SS PEG20, 000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res 62:5443–5450

    PubMed  CAS  Google Scholar 

  5. Feun L, Savaraj N (2006) Pegylated arginine deiminase: a novel anticancer enzyme agent. Expert Opin Investig Drugs 15:815–822

    Article  PubMed  CAS  Google Scholar 

  6. Gong H, Zolzer F, von Recklinghausen G et al (2000) Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia 14:826–829

    Article  PubMed  CAS  Google Scholar 

  7. Izzo F, Marra P, Beneduce G et al (2004) Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from Phase I/II studies. J Clin Oncol 22:1815–1822

    Article  PubMed  CAS  Google Scholar 

  8. Kim JE, Jeong DW, Lee HJ (2007) Expression, purification, characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21. Protein Expr Purif 53:9–15

    Article  PubMed  CAS  Google Scholar 

  9. Liu YM, Sun ZH, Ni Y et al (2008) Isolation and identification of an arginine deiminase producing strain Pseudomonas plecoglossicida CGMCC2039. World J Microb Biot 24:2213–2219

    Article  CAS  Google Scholar 

  10. Misawa S, Aoshima M, Takaku H et al (1994) High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme. J Biotechnol 36:145–155

    Article  PubMed  CAS  Google Scholar 

  11. Ni Y, Schwaneberg U, Sun ZH (2008) Arginine deiminase, a potential anti-tumor drug. Cancer Lett 261:1–11

    PubMed  CAS  Google Scholar 

  12. Oudjama Y, Tricot C, Stalon V et al (2002) Overexpression, purification, crystallization and preliminary X-ray crystallographic analysis of Pseudomonas aeruginosa l-arginine deiminase. Acta Crystallogr D Biol Crystallogr 58:2150–2152

    Article  PubMed  Google Scholar 

  13. Park IS, Kang SW, Shin YJ et al (2003) Arginine deiminase: a potential inhibitor of angiogenesis and tumor growth. Br J Cancer 89:907–914

    Article  PubMed  CAS  Google Scholar 

  14. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor

    Google Scholar 

  15. Shen LJ, Shen WC (2006) Drug evaluation: ADI-PEG-20—a PEGylated arginine deiminase for arginine-auxotrophic cancers. Curr Opin Mol Ther 8:240–248

    PubMed  CAS  Google Scholar 

  16. Shirai H, Blundell TL, Mizuguchi K (2001) A novel superfamily of enzymes that catalyze the modification of guanidino groups. Trends Biochem Sci 26:465–468

    Article  PubMed  CAS  Google Scholar 

  17. Sun ZH, Zheng P, Ni Y et al (2007) An arginine deiminase producing strain and its application. Chinese patent (Application No. 200710107822.X)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ye Ni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ni, Y., Li, Z., Sun, Z. et al. Expression of Arginine Deiminase from Pseudomonas plecoglossicida CGMCC2039 in Escherichia coli and Its Anti-Tumor Activity. Curr Microbiol 58, 593–598 (2009). https://doi.org/10.1007/s00284-009-9376-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00284-009-9376-0

Keywords

Navigation